Yash Brahmbhatt

Mr. Yash Brahmbhatt

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2024 in Life
Verified
Journal Article
Open access
PDF file
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
HAHend Alqaderi
Hend Alqaderi
ZCZahra Chinipardaz
Zahra Chinipardaz
(1) Background: Periodontal disease, a progressive inflammatory condition, disrupts the oral microbiome and releases inflammatory cytokines, leading to systemic issues, including cognitive decline. This study investigates the association between severe periodontitis and cognitive decline, exploring the role of alkaline phosphatase (ALP), an enzyme linked to systemic inflammation, as an effect modifier. (2) Methods: We analyzed cross-sectional data from the 2013–2014 National Health and Nutrition Examination Survey (NHANES). Severe periodontitis was defined using the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) case definition. A weighted multivariable logistic regression model assessed the association between severe periodontitis and cognitive decline. An interaction term examined ALP’s role as an effect modifier. (3) Results: This study included 1265 participants aged 65 and older. After adjusting for confounders, each one-point increase in cognitive function score was associated with a 2% decrease in the odds of severe periodontitis (OR = 0.98; 95% CI = 0.97–0.99; p = 0.008). ALP was a significant effect modifier in the relationship between severe periodontitis and cognitive decline. (4) Conclusions: This study, using a representative U.S. adult population aged 65 and over, suggests that lower cognitive performance correlates with higher likelihood of severe periodontitis. ALP enhances the association between severe periodontitis and cognitive decline.

26 June 2025 in International Dental Journal
Verified
Journal Article
Open access
WAWoroud Nasser Al-Sulimmani
Woroud Nasser Al-Sulimmani
AAAsmaa Al-Rasheed
Asmaa Al-Rasheed
HAHebah Al-Daraan
Hebah Al-Daraan
MAMuna Al-Mutairi
Muna Al-Mutairi
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
HAHend Al-Qaderi
Hend Al-Qaderi
This systematic review and meta-analysis were conducted to compare the failure risk between amalgam and composite resin materials in permanent posterior teeth. Study eligibility requirements included clinical trials and observational studies with at least 12 months of follow-up. English-language studies from 1990 onwards were the only studies included. This review follows the Cochrane Handbook for Systematic Reviews of Interventions and the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Our search strategy included using the following databases: PubMed, Cochrane, and Google Scholar. The primary outcome was restoration failures, defined as restoration replacements, tooth and restoration fractures, secondary caries, postoperative sensitivity, and toothaches. We conducted a random-effects meta-analysis to determine the risk ratio (RR) of the included studies, and publication bias was assessed. The Cochrane Risk of Bias tool was employed to evaluate the quality of the clinical trials, while the Newcastle-Ottawa scale was used to assess the quality of other studies. The results were derived from 13 studies. The failure proportion for amalgam ranged from 0% to 50.0%, while that of composite resin restorations ranged from 0% to 62.7%. The meta-analysis did not find any statistically significant difference in failure risk between amalgam and composite resin restorations (RR: 0.96, 95% confidence intervals: 0.68-1.34). The Egger's test results did not show any significant evidence of publication bias in the meta-analysis (P > .05). This review did not reveal any statistically significant difference in the RR between composite resin and amalgam restorations. However, in their analyses, the 13 studies used varying definitions of failure and did not account for some important factors that might have influenced restoration failures. Future reviews need to account for other influential variables that contributed to restoration failures.

11 June 2025 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
PAPraewvanit Asavanamuang
Praewvanit Asavanamuang
PSPiyarat Sirirattanagool
Piyarat Sirirattanagool
SJShruti Jain
Shruti Jain
LTLorenzo Tavelli
Lorenzo Tavelli
MFMatthew Finkelman
Matthew Finkelman
MGMaria Elisa Galarraga‐Vinueza
Maria Elisa Galarraga‐Vinueza

3 May 2025 in Life
Verified
Journal Article
Open access
PDF file
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
MZMichelle Zak
Michelle Zak
RARazan Alhajri
Razan Alhajri
NANoura Almulla
Noura Almulla
SASakeenah Alqallaf
Sakeenah Alqallaf
HAHend Alqaderi
Hend Alqaderi
(1) Background: Ethylene oxide (EtO), an environmental pollutant, has been linked to adverse health outcomes through its genotoxic, oxidative stress inducing, and alkylating properties, including potential impacts on oral health. This study explores the association between EtO serum levels and complete edentulism. (2) Methods: Data were analyzed from the 2017–2018 National Health and Nutrition Examination Survey (NHANES) dataset using logistic regression analysis to examine the relationship between EtO serum levels and complete edentulism, adjusting for age, sex, education, race, and diabetes status, and periodontal disease, including a total of 19,225 participants. Of the 19,225 participants, 4933 individuals (25.66%) were completely edentulous, and 14,292 (74.34%) were not. (3) Results: Higher EtO serum levels were associated with increased odds of complete edentulism (OR = 1.61; 95% CI = 1.35–1.93; p ≤ 0.001), adjusting for the confounders mentioned above. (4) Conclusions: This analysis of a representative sample of the U.S. adult population showed that individuals exposed to higher levels of EtO had total tooth loss, underscoring the importance of addressing environmental factors in oral health. Further research is needed to understand the mechanism of EtO exposure on oral health.

2 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RGRipple Garg
Ripple Garg
SPSarah Pagni
Sarah Pagni
AAAhmad Alkandari
Ahmad Alkandari
AAAbrar Alkhesaili
Abrar Alkhesaili
NANouf Alsheredah
Nouf Alsheredah
HAHend Alqaderi
Hend Alqaderi
Metabolic syndrome (MetS) is a global health concern characterized by a cluster of metabolic abnormalities, including central obesity, hypertension, hyperglycemia, and dyslipidemia, which increase the risk of cardiovascular disease and type 2 diabetes. This systematic review and meta-analysis aimed to assess the diagnostic value of salivary C-reactive protein (CRP) as a non-invasive biomarker for MetS. A comprehensive search of PubMed, Cochrane Library, and Web of Science was conducted through December 2024. Eligible studies reported salivary CRP levels in individuals with and without MetS. Two independent reviewers extracted data on study design, demographics, CRP measurement methods, and diagnostic criteria for MetS. Meta-analyses were performed using random-effects models to calculate pooled standardized mean differences (SMDs) with 95% confidence intervals. Among 863 records screened, 19 studies involving 3,157 participants met the inclusion criteria. The pooled results showed significantly higher salivary CRP levels in individuals with MetS compared to controls (Hedges’ g = 1.02; 95% CI: | 0.23, 1.81] P = 0.01). High between-study heterogeneity was observed (I² = 98.91%, P < 0.001), and funnel plot asymmetry suggested potential publication bias or underlying heterogeneity. These findings suggest that salivary CRP may serve as a promising non-invasive biomarker for detecting metabolic syndrome.

2 March 2026 in Life
Verified
Journal Article
Open access
PDF file
MKMohammad Khalfan
Mohammad Khalfan
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
SPSarah Pagni
Sarah Pagni
RGRipple Garg
Ripple Garg
AAAhmad A. Alkandari
Ahmad A. Alkandari
HAHend Alqaderi
Hend Alqaderi
Metabolic syndrome (MetS) is a cluster of conditions that rely on low-grade systemic inflammation and increase the risk of cardiovascular disease, type 2 diabetes, and stroke. C-reactive protein (CRP) has attracted growing interest in saliva as a non-invasive alternative to serum CRP testing, though existing evidence remains inconsistent. This systematic review and meta-analysis evaluated the association between salivary CRP levels and MetS and examined the consistency of findings across populations and methodological approaches. PubMed, the Cochrane Library, and Web of Science were searched up to December 2024 following PRISMA 2020 guidelines. Nineteen studies involving 3265 participants with and without MetS were included. Random-effects meta-analysis demonstrated higher salivary CRP levels in individuals with MetS compared with controls (SMD = 1.02; 95% CI −0.23 to 1.81), with substantial heterogeneity (I2 = 98.91%), reflecting variation in population characteristics and saliva collection protocols. Funnel plot assessment did not indicate publication bias. Despite considerable heterogeneity, pooled estimates suggest that individuals with MetS have higher levels of salivary CRP. Longitudinal studies employing standardized methodologies are required before its clinical implementation can be considered.